Arkansas Children’s Patient is First in State to Receive FDA-Approved DMD Gene Therapy

Wesley was 9 months old when he was diagnosed with DMD, a highly progressive, rare muscular dystrophy impacting boys. As a baby, Wesley began having febrile seizures. While other hospitals could not figure out what was wrong, their family was finally given answers when they came to Arkansas Children's Hospital. Watch Wesley's story and learn how gene therapy along with the latest technologies and research are being used to help treat patients at Arkansas Children's.

At Arkansas Children’s, our nationally renowned specialists give expert care for children suffering from a wide range of neurological disorders, treating brain, nervous system, and neuromuscular disorders.

Our team of specialists works together through a multidisciplinary approach to clinical collaboration so each child has an entire team of experts personalizing care for improved outcomes. Our goal through this team approach is to maximize your child’s development and quality of life. Our team provides state-of-the-art care to transition our patients through life - from birth through childhood, adolescence and into early adulthood.

With leading-edge research to advance knowledge, we are creating new approaches to improved patient care in many areas of neurological and neurosurgical care.
----------

[rameshkannarameshkanna]

DMD can cure in this medicine please respond

[anuchaudhary]

My son is suffering from duchenne muscular dystrophy.But this gene therapy is very very costly.I won't be able to afford it.